Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.

Details

Serval ID
serval:BIB_D7A4B8D24794
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.
Journal
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Author(s)
Haanen J., Los C., Phan G.Q., Betof Warner A.
ISSN
1548-8756 (Electronic)
ISSN-L
1548-8748
Publication state
Published
Issued date
06/2024
Peer-reviewed
Oui
Volume
44
Number
3
Pages
e431608
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.
Keywords
Humans, Melanoma/therapy, Immunotherapy, Adoptive/methods, Neoplasms/therapy, Treatment Outcome
Pubmed
Create date
24/05/2024 8:41
Last modification date
25/05/2024 6:14
Usage data